Blueprint Medicines(BPMC) - 2022 Q4 - Earnings Call Transcript

Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2022 Earnings Conference Call February 16, 2023 8:00 AM ET Company Participants Jenna Cohen - Senior Director and Head of Investor Relations Kate Haviland - Chief Executive Officer Philina Lee - Chief Commercial Officer Christy Rossi - Chief Operating Officer Mike Landsittel - Chief Financial Officer Fouad Namouni - President of Research and Development Becker Hewes - MD, Chief Medical Officer Conference Call Participants Dane Leone - Raymond James Ernie Rodr ...